WO2024153406 - A SUBASSEMBLY OF A MEDICAMENT DELIVERY DEVICE
National phase entry is expected:
Publication Number
WO/2024/153406
Publication Date
25.07.2024
International Application No.
PCT/EP2023/085563
International Filing Date
13.12.2023
Title **
[English]
A SUBASSEMBLY OF A MEDICAMENT DELIVERY DEVICE
[French]
SOUS-ENSEMBLE D'UN DISPOSITIF D'ADMINISTRATION DE MÉDICAMENT
Applicants **
SHL MEDICAL AG
Inventors
SINGH, Amit
ATES, Iskender Okan
Priority Data
63/439,344
17.01.2023
US
23160094.1
06.03.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2092 | |
| EPO | Filing, Examination, Granting | 8491 | |
| Japan | Filing, Examination, Granting | 2136 | |
| South Korea | Filing, Examination, Granting | 1920 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,379
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
A subassembly (2) of a medicament delivery device (1) comprising a cover structure (5) with a first latching element (53) and a retaining structure (3) having an envelope surface (32) arranged radially outside of the cover structure (5) and having a second latching element (33). In a first extended position of the cover structure (5), the first latching element (53) is out of engagement and positioned distally with respect to the second latching element (33). In a second extended position, the first latching element (53) is in mutual engagement with respect to the second latching element, such that the cover structure (5) is prevented from moving towards a retracted position. In the second extended position, the envelope surface (32) covers or surrounds the first and/or the second latching element, in order to prevent disengagement of the first latching element (53) and the second latching element (33) by a user.[French]
Sous-ensemble (2) d'un dispositif d'administration de médicament (1) comprenant une structure de couvercle (5) avec un premier élément de verrouillage (53) et une structure de retenue (3) ayant une surface d'enveloppe (32) disposée radialement à l'extérieur de la structure de couvercle (5) et ayant un second élément de verrouillage (33). Dans une première position étendue de la structure de couvercle (5), le premier élément de verrouillage (53) n'est pas en prise et positionné de manière distale par rapport au second élément de verrouillage (33). Dans une seconde position étendue, le premier élément de verrouillage (53) est en prise mutuelle par rapport au second élément de verrouillage, de telle sorte que la structure de couvercle (5) est empêchée de se déplacer vers une position rétractée. Dans la seconde position étendue, la surface d'enveloppe (32) recouvre ou entoure le premier et/ou le second élément de verrouillage, afin d'empêcher le désengagement du premier élément de verrouillage (53) et du second élément de verrouillage (33) par un utilisateur.